Schizophrenia

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

News

Large Study Implicates 10 Genes in Schizophrenia Development

12/02/2019

In a study incorporating genetic data from more than 125,000 people, researchers have implicated 10 new genes in the development of schizophrenia.

In a study incorporating genetic...

12/02/2019

Psych Congress Network

Q&A

Palate Significantly Wider in People With Schizophrenia With Primary Negative Symptoms

10/21/2019

Brian Kirkpatrick, MD, and Gary Hack, DDS, discuss a recently published study examining palate width in subgroups of people with schizophrenia.

Brian Kirkpatrick, MD, and Gary...

10/21/2019

Psych Congress Network

Future Opportunities in the Treatment of Schizophrenia

12/19/2018

Anticipate some significant changes in the treatment of schizophrenia over the next 10 years, from a move toward coordinated specialty care to harnessing the power of social media to help identify symptoms sooner, said John M. Kane, MD.

Anticipate some significant...

12/19/2018

Psych Congress Network

Tips for Starting Patients on Long-Acting Injectables

07/10/2018

Ilan Melnick, MD, staff psychiatrist and chief medical officer, Passageway Residences of Dade County, Miami, Florida, answers questions about initiating long-acting injectable antipsychotics in patients.

Ilan Melnick, MD, staff...

07/10/2018

Psych Congress Network

Videos

Spotlight on Schizophrenia With Dr. Leslie Citrome

05/18/2018

Leslie Citrome, MD, MPH, discusses the link between schizophrenia and diabetes, the role of metabolic syndrome, weight gain from antipsychotics, and interventions for patients with schizophrenia.

Leslie Citrome, MD, MPH,...

05/18/2018

Psych Congress Network

The Role of Inflammation in the Pathophysiology of Schizophrenia

04/03/2018

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses whether inflammation has a role in the underpinnings of schizophrenia, and if anti-inflammatory treatments could have benefit.

Psych Congress Steering...

04/03/2018

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Schizophrenia Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products